Orthostatic hypotension and postural tachycardia (POTS)
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Confirmed orthostatic hypotension
In the practice
- Blood pressure and heart rate after 5 minutes lying then 3 minutes standing; ECG; medication review.
Laboratory tests
- FBC
- Serum electrolytes
- Serum creatinine with eGFR
- Fasting plasma glucose
- TSH
- Vitamin B12
- Serum protein electrophoresis (if associated peripheral neuropathy, to look for a monoclonal gammopathy)if needednon-French guidelineOrthostatic hypotension with signs of peripheral neuropathy: the 2017 American consensus places this test second-line, in these patients, to look for a monoclonal gammopathy [2]. The French consensus lists amyloidosis among the causes, without a list of tests [3].
Also consider
- Adrenal insufficiency suspected? For fatigue, hyponatraemia, hyperkalaemia or stopped corticosteroid therapy, see the "Adrenal insufficiency" page.
Suspected postural tachycardia (POTS)
In the practice
- Heart rate and blood pressure lying then standing (standing for more than 30 seconds); 12-lead ECG.
Laboratory tests
- FBC
- TSH
On midodrine or fludrocortisone: monitoring
Laboratory tests
- Serum creatinine with eGFR (midodrine: before treatment, then regularly long term)if neededPatient on midodrine (Gutron): contraindicated in severe renal failure; long-term monitoring of kidney function advised (SmPC) [10].
- ASTif needednon-French guidelinePatient on midodrine: the UK SmPC recommends assessing kidney and liver parameters before treatment and then regularly, as there are no studies in hepatic impairment [11]; the Dutch formulary asks for liver and kidney checks before treatment [12]. The French SmPC cites long-term kidney monitoring, not liver monitoring [10].
- ALTif needednon-French guidelinePatient on midodrine: the UK SmPC recommends assessing kidney and liver parameters before treatment and then regularly, as there are no studies in hepatic impairment [11]; the Dutch formulary asks for liver and kidney checks before treatment [12]. The French SmPC cites long-term kidney monitoring, not liver monitoring [10].
- Serum electrolytes (fludrocortisone: potassium and sodium)if neededPatient on fludrocortisone (off-label for this indication): monitor serum potassium and sodium, with blood pressure and weight [3].
Sources (15)
- Kim MJ, Farrell J. Orthostatic hypotension: a practical approach. Am Fam Physician. 2022;105(1):39-49.
- Gibbons CH, Schmidt P, Biaggioni I, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264(8):1567-1582.
- Pathak A, Elghozi JL, Fortrat JO, Senard JM, Hanon O. Prise en charge de l’hypotension orthostatique. Consensus d’experts de la Société française d’hypertension artérielle (SFHTA), de la Société française de gériatrie et gérontologie (SFGG) et de l’European Federation of Autonomic Societies (EFAS). Décembre 2014.
- Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883-1948.
- National Institute for Health and Care Excellence (NICE). Transient loss of consciousness ('blackouts') in over 16s. Clinical guideline CG109, août 2010, mise à jour 21 novembre 2023.
- National Institute for Health and Care Excellence (NICE). Falls: assessment and prevention in older people and in people 50 and over at higher risk. Guideline NG249, 29 avril 2025.
- Montero-Odasso M, van der Velde N, Martin FC, et al. World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing. 2022;51(9):afac205.
- Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12(6):e41-63.
- Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Auton Neurosci. 2021;235:102828.
- Résumé des caractéristiques du produit GUTRON 2,5 mg, comprimé (midodrine). Base de données publique des médicaments, RCP mis à jour le 17/05/2021.
- Summary of product characteristics. Bramox 2.5 mg tablets (midodrine). electronic medicines compendium (Royaume-Uni), texte révisé le 19/04/2022.
- Zorginstituut Nederland. Farmacotherapeutisch Kompas : midodrine (Pays-Bas), consulté le 30 octobre 2026.
- Federatie Medisch Specialisten (Pays-Bas). Preventie van valincidenten bij ouderen : module « Medicamenteuze behandeling van orthostatische hypotensie » (2023 ; publié sur le site le 19/02/2026, validité évaluée le 06/02/2024). Richtlijnendatabase.
- National Institute for Health and Care Excellence (NICE). Parkinson's disease in adults. Guideline NG71, 19 juillet 2017.
- Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope. J Am Coll Cardiol. 2017;70(5):e39-e110.